Identification of a Negative Element in the Human Vimentin Promoter: Modulation by the Human T-Cell Leukemia Virus Type I Tax Protein

REFERENCES

• Dignam, J. D., R. Μ. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Fahraeus, R., A. Jansson, A. Ricksten, A. Sjoblom, and L. Rymo. 1990. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein by the activity of a negative regulatory element. Proc. Natl. Acad. Sci. USA 87:7390–7394.
   PubMed Web of Science ®Google Scholar
• Farrell, F. X., C. M. Sax, and Z. E. Zehner. 1990. A negative element involved in vimentin gene expression. Mol. Cell. Biol. 10:2349–2358.
   PubMedGoogle Scholar
• Fujii, Μ., P. Sassone-Corsi, and I. Μ. Verma. 1988. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 85:8526–8530.
   PubMed Web of Science ®Google Scholar
• Fujisawa, J., Μ. Seiki, Μ. Sato, and Μ. Yoshida. 1986. A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40x of HTLV-L EMBO J. 5:713–718.
   PubMedGoogle Scholar
• Gibson, C. W., S. R. Rittling, R. R. Hirschhorn, L. Kaczamarek, B. Calabretta, C. D. Stiles, and R. Baserga. 1986. Cell cycle dependent genes inducible by different mitogens in cells from different species. Mol. Cell. Biochem. 71:61–69.
   PubMed Web of Science ®Google Scholar
• Gorman, C. Μ., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Herbst, R. S., E. Μ. Boczko, J. E. Darnell, Jr., and L. E. Babiss. 1990. The mouse albumin enhancer contains a negative regulatory element that interacts with a novel DNA-binding protein. Mol. Cell. Biol. 10:3896–3905.
   PubMedGoogle Scholar
• Kaczamarek, L., B. Calabretta, and R. Baserga. 1985. Expression of cell-cycle dependent genes in phytohemagglutinin-stimulated human lymphocytes. Proc. Natl. Acad. Sci. USA 82:5375–5379.
   PubMedGoogle Scholar
• Kim, S., J. H. Kehri, J. Burton, C. L. Tendler, K. Jeang, D. Danielpour, C. Thevenin, K. Y. Kim, Μ. B. Sporn, and A. B. Roberts. 1990. Transactivation of the transforming growth factor bl(TGF-βl) gene by human T Iymphotropic virus type I Tax: a potential mechanism for the increased production of TGF-βl in adult T cell leukemia. J. Exp. Med. 172:121–129.
   PubMed Web of Science ®Google Scholar
• Lenardo, Μ. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227–229.
   PubMed Web of Science ®Google Scholar
• Lilienbaum, A., Μ. Due Dodon, C. Alexandre, L. Gazzolo, and D. Paulin. 1990. Effect of human T-cell leukemia virus type I Tax protein on activation of the human vimentin gene. J. Virol. 64:256–263.
   PubMedGoogle Scholar
• Lilienbaum, A., and D. Paulin. The human vimentin gene: mechanisms of regulation by NF-kappa-related transcriptional factors. J. Biol. Chem., in press.
   Google Scholar
• Lucknow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eucaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
   PubMedGoogle Scholar
• Markovitz, D. G., S. P. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic cell line. Virology 167:400–406.
   PubMedGoogle Scholar
• Marriot, S. J., P. F. Lindholm, K. M. Brown, S. D. Gitlin, J. F. Duvall, Μ. F. Radonovich, and J. N. Brady. 1990. A 36- kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat. Mol. Cell. Biol. 10:4192–4201.
   PubMedGoogle Scholar
• May, E., F. Omilli, J. Borde, and P. Scieller. 1992. Simian virus 40 T antigen activates the late promoter by modulating the activity of negative regulatory elements. J. Virol. 66:3347–3354.
   PubMedGoogle Scholar
• Miller, A. D., and G. J. Rosaman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980–990.
   PubMed Web of Science ®Google Scholar
• Mitchell, P. J., and R. Tjian. 1989. Transcriptional regulation in mammalian ceUs by sequence-specific DNA binding proteins. Science 245:371–378.
   PubMed Web of Science ®Google Scholar
• Miyatake, S., Μ. Seiki, Μ. Yoshida, and K. Arai. 1988. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol. CeU. Biol. 8:5581–5587.
   PubMed Web of Science ®Google Scholar
• Neumann, J∙ R., C. A. Morency, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques 5:444–447.
   Web of Science ®Google Scholar
• Pinset, C., D. Montarras, J. Chenevert, A. Minty, P. Barton, C. Laurent, and F. Gros. 1988. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation 38:28–34.
   PubMed Web of Science ®Google Scholar
• Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415–7419.
   PubMed Web of Science ®Google Scholar
• Rittling, S. R., and R. Baserga. 1987. Functional analysis and growth factor regulation of the human vimentin promoter. Mol. Cell. Biol. 7:3908–3915.
   PubMed Web of Science ®Google Scholar
• Ruoqian-Shen, S. K. Goswami, E. Mascareno, A. Kumar, and Μ. A. Q. Siddiqui. 1991. Tissue-specific transcription of the caridac myosin light-chain 2 gene is regulated by an upstream repressor element. Mol. Cell. Biol. 11:1676–1685.
   PubMedGoogle Scholar
• Seieller, P., F. Omilli, J. Borde, and J. May. 1991. Characterization of SV40 enhancer motifs involved in positive and negative regulation of the constitutive late promoter activity; effect of T-antigen. Virology 181:783–786.
   PubMedGoogle Scholar
• Seiki, Μ., J. Inoue, T. Takeda, A. Hikikoshi, Μ. Sato, and Μ. Yoshida. 1985. The p40x of human T-cell leukemia virus type I is a transactivator of viral gene transcription. Jpn. J. Cancer Res. 76:1127–1131.
   PubMedGoogle Scholar
• Seiki, Μ., J. Inoue, T. Takeda, and Μ. Yoshida. 1986. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J. 5:561–565.
   PubMed Web of Science ®Google Scholar
• Siekevitz, Μ., Μ. B. Feinberg, N. Holbrook, F. Wong-Staal, and W. C. Greene. 1987. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the transactivator (tat) gene product of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 84:5389–5393.
   PubMed Web of Science ®Google Scholar
• Smith, Μ. R., and W. C. Greene. 1991. Molecular biology of the type I human T cell leukemia virus (HTLV) and adult T cell leukemia. J. Clin. Invest. 87:761–766.
   PubMed Web of Science ®Google Scholar
• Sodroski, J. G., C. A. Rosen, and W. A. Haseltine. 1984. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381–385.
   PubMed Web of Science ®Google Scholar
• Whittemore, L., and T. Maniatis. 1990. Postinduction repression of the β-interferon gene is mediated through two positive regulatory domains. Proc. Natl. Acad. Sci. USA 87:7799–7803.
   PubMedGoogle Scholar
• Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031–2035.
   PubMed Web of Science ®Google Scholar
• Zhenlin, L., and D. Paulin. 1991. High level desmin expression depends on a muscle-specific enhancer. J. Biol. Chem. 266:6562–6570.
   PubMedGoogle Scholar